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Approximately 39% of methicillin-resistant Staphylococcus aureus (MRSA) sequence type 239 (ST239)-like bloodstream isolates
from Liverpool Hospital (obtained between 1997 and 2008) carry an arginine catabolic mobile element (ACME).Whole-genome
sequencing revealed that an ACME II variant is located between orfX and SCCmec III, and based on pulsed-field gel electropho-
resis patterns and temporal relationships of all ST239-like isolates (n 360), ACME carriage may have contributed to subpulso-
type strain replacement.
Strains of methicillin-resistant Staphylococcus aureus (MRSA)are a major cause of health care-associated infections around
the world and are an emerging cause of infections in the wider
community. In Australia, MRSA accounts for approximately 24%
of S. aureus bloodstream infections and is associated with in-
creased health care costs, morbidity, and mortality (16).
The arginine catabolic mobile element (ACME) is a putative
virulence/colonization determinant that integrates into the chro-
mosome at the same attachment site as staphylococcal chromo-
some cassette mec (SCCmec), presumably via the utilization of
SCCmec-encoded cassette recombinases (2, 4, 5). ACME allotypes
are defined by the presence or absence of the arc and opp-3 gene
clusters (type I, arc opp-3; type II, arc opp-3; type III, arc
opp-3), and carriage of this element is thought to provide a com-
petitive survival advantage. In this regard, the arc gene cluster
(arcCBDAR) encodes a complete arginine deiminase pathway,
which converts L-arginine to carbon dioxide, ATP, and ammonia,
the last of which is important for survival at lowpH (4). In general,
ACMEallotypes (and variants thereof) are broadly associatedwith
certain coagulase-negative staphylococci (CoNS) (2, 10, 12).
ACME carriage is uncommon in MRSA isolates, with the excep-
tion of USA300 (ST8-MRSA-IVa), for which evidence suggests
that carriage has contributed to the successful spread of this com-
munity clone; a previous study showed that deletion of ACME I
resulted in a fitness loss for a USA300 strain in a rabbit bacteremia
model (5).
In this study, we examined the incidence of ACME carriage
with respect to MRSA sequence type 239 (ST239)-like blood-
stream isolates at Liverpool Hospital, Sydney, Australia, between
1997 and 2008. All 360 ST239-like isolates had previously
been typed via pulsed-field gel electrophoresis (PFGE) using
HARMONY criteria against known multilocus sequence-typed
controls (15, 16); isolates were not subjected to multilocus se-
quence typing and are therefore referred to as ST239-like. Subse-
quently, we screened these isolates for the presence of an ACME
allotype (I and II only) by directed arcA PCR (5). Whole-genome
sequencing (WGS) was utilized to further characterize the ACME
region in one arcA-positive isolate (Sa0059). A fragment library
was generated and sequenced on an Ion Torrent PGM (Life Tech-
nologies, Carlsbad, CA) according to the manufacturer’s instruc-
tions. A de novo assembly was generated using the CLC genomics
workbench (CLC bio, Denmark), resulting in 1,437 contigs with
an N50 of 2,501 bp and a maximum contig length of 16,659 bp.
Contigs were ordered against JKD6008 (GenBank accession num-
ber CP002120), a recently described Australasian ST239-MRSA-
III isolate (8), usingMauve contigmover (13). Gap closure for the
orfX-ACME-SCCmec region was performed by sequencing PCR
products using an ABI 3730xl capillary sequencer (Macrogen). A
similar ACME allotypewas inferred if the location of the ACME in
other arcA-positive isolates was similar to that of Sa0059, as deter-
mined by directed PCR across the orfX-ACME junction using prim-
ers orfX-SE_0098-F (5=-GTTCCAGACGAAAAAGCACC-3=) and
orfX-SE_0098-R (5=-ATTTTACTATCATATGGTTCAC-3=).
During the study period, ST239-like isolates accounted for
78.6% (360/458) of all MRSA isolates and displayed a high degree
of diversity with 61 PFGE subpulsotypes. Unweighted pair group
method with arithmetic mean (UPGMA) dendrogram analysis
revealed that these subpulsotypes clustered into five distinct clades
(Fig. 1A), with clades 1 and 4 collectively accounting for 87.5%
(315/360) of all ST239-like isolates. Interestingly, analysis of tem-
poral relationships revealed that a subpulsotype strain replace-
ment event had occurred; isolates from clade 4 (CL4) peaked in
2002 and were completely replaced by those from clade 1 (CL1) in
2008 (Fig. 1B). Screening of isolates for an ACME allotype re-
vealed that 88%of CL1 isolates tested were positive for arcA, com-
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pared to only 5.5% of CL4 isolates (Table 1). A detailed analysis of
contigs obtained from sequencing the CL1 isolate Sa0059 that did
not order against JKD6008 (44/1,437 contigs) revealed a genomic
region located between orfX and SCCmecIII (Fig. 2B) that was
identical to ACME II, a novel ACME II variant recently identi-
fied in ST22 isolates from Ireland (14) (Fig. 2A); 9 contigs were
associated with this region. The remaining 35 contigs that did not
order against JKD6008 displayed homology to the core genome of
various staphylococcal bacteriophages and the genomic island
vSa (type II) (1). While the latter encodes putative virulence
factors, this genomic island is commonly present in MRSA (in-
cluding other sequenced ST239 strains) (7, 9), and its distribution
among our ST239-like isolates was not further examined. Note
that all arcA-positive ST239-like isolates most likely carried
ACME II, as they were also positive for orfX-SE_0098.
This is the first genetic characterization of an ACME allotype in
MRSA ST239-like isolates and the first report of ACME II in Aus-
tralia. Inaddition,ourdata suggest that carriageof thisACMEvariant
may have been, at least in part, responsible for the observed subpul-
sotype replacement event. Thus, ACME II may be contributing to
the competitive fitness ofCL1 isolates and their ability to colonize the
skin and mucosal surfaces, as proposed for ACME I with respect to
the successful spread of USA300 (4, 5). In this regard, it is interesting
to note that the arcA-positive CL4 isolates (although limited in num-
ber) are temporally spread throughout the study period, similar to
those of CL1, implying that the genetic background of CL1 isolates is
more amenable to the carriage ofACME II.
FIG1 (A)UPGMAdendrogram showing the fivemajor clades of representative ST239-like PFGEpatterns (LiverpoolHospital; 1997 to 2008) that was generated
using BioNumerics (AppliedMaths, Kortrijk, Belgium). The asterisk denotes a single PFGE pattern that does not cluster within themajor clades (1 to 5), and the
Sa0059 (clade 1 isolate) pulsotype is boxed. (B) Distribution of ST239-like isolates per clade during the study period.
TABLE 1 PCR screening for the presence of arcA in ST239 MRSA
isolates
Clade
No. of
isolates
No. (%) of isolates with each arcA statusa
Positive Negative Not testedb
1 149 125 (88) 17 (12) 7
2 11 0 (0) 10 (100) 1
3 13 1 (7.7) 12 (92.3)
4 166 9 (5.5) 154 (94.5) 3
5 20 0 (0) 20 (100)
All cladesc 360 135 (38.7) 214 (61.3) 11
a Percentage of total isolates tested.
b Isolates could no longer be cultured from the original glycerol stock.
c Includes the single isolate represented by the PFGE pattern that does not cluster
within the major clades (see Fig. 1).
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Previous studies by Ghaznavi-Rad et al. (6) andMonecke et al.
(11) also detected the arcA gene in ST239 isolates (albeit at low
levels), but in each case, the ACME allotype was not further char-
acterized. As ACME II has been described only in ST22-MRSA-
IVh isolates from Dublin, Ireland (14), ST22 may represent an
MRSA reservoir of this ACME II variant; ST22-like isolates were
also recovered from Liverpool Hospital during the study period
(15, 16). However, as the isolates from Ireland represent a distinct
ST22-MRSA-IV strain, it is also likely that the ACME II identi-
fied in our study was independently obtained (by ST239) from a
coagulase-negative staphylococcal source due to the prevalence
and exclusivity of ACME II in CoNS. In support of this, Bartels et
al. (3) recently described a USA300-related strain that had ac-
quired an ACME II variant (similar to ACME II) that was most
likely from a Staphylococcus epidermidis background. In any case,
the emergence ofACME II inMRSA ST239-like isolates suggests
that unlike ACME I, this ACME II variant may provide a selective
advantage to a number of differentMRSA sequence types and thus
more broadly enhance the dissemination of already successful
MRSA clones that are resistant to multiple antimicrobial agents.
Furthermore, our results emphasize the central role that mobile
elements play in the acquisition of new properties and, thus, the
“short-term” evolution of this important human pathogen. Addi-
tional studies are required to demonstrate the advantageous po-
tential of ACME II carriage and to ascertain if the genetic back-
ground of CL1 ST239-like isolates (in comparison to that of CL4
isolates, for example) is more amenable to harboring an ACME
allotype.
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